Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness
ShutterstockThe Therapeutic Goods Administration (TGA) is considering rescheduling psilocybin and MDMA from their current classification as Schedule 9 prohibited substances to Schedule 8 controlled substances.
This would allow psychiatrists to use these drugs in combination with psychotherapy for the treatment of conditions such as depression and...




